---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-23-034146"
form_type: "8-K"
ticker: "FLNA"
cik: "0001069530"
company_name: "FILANA THERAPEUTICS, INC."
filed_at: "2023-12-12T23:59:59+00:00"
generated_at: "2026-06-07T13:58:21.928932+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Cassava Sciences declares warrant distribution; holders get 4 warrants per 10 shares, exercise price $33

## Summary
- Stockholders of record Dec 22, 2023 receive 4 warrants per 10 shares, free of charge; distributed Jan 3, 2024.
- Each warrant exercisable for one share at $33; warrants expected to trade on Nasdaq under ticker 'SAVAW'.
- Early exercise before Bonus Share Expiration yields additional 0.5 common share per warrant, effective price ~$22.
- Warrants expire Nov 15, 2024; redeemable by company after Apr 15, 2024 on 20 days' notice.
- Proceeds from warrant exercises to fund Phase 3 clinical trials of oral simufilam for Alzheimer's disease.

## SEC filing metadata
- accession: 0001437749-23-034146
- form_type: 8-K
- ticker: FLNA
- cik: 0001069530
- company_name: FILANA THERAPEUTICS, INC.
- filed_at: 2023-12-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069530/000143774923034146/0001437749-23-034146-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069530/000143774923034146/sava20231211_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-23-034146
- JSON: https://secwatch.observer/filing/0001437749-23-034146.json
- Plain text: https://secwatch.observer/filing/0001437749-23-034146.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.